At VBS Molecular Diagnostics, our mission is to take the guesswork out of medicine. We do this by providing molecular analytical services to interpret tissue-specific disease information contained in endoarterial biopsy samples.Our capabilities include:
Next Generation Sequencing Data Analysis
Through the use of our diagnostic systems, sequencing the entire human genome — which used to take months of extensive collaboration — can be done by one scientist in a matter of days, expediting the diagnosis and treatment of serious diseases. Expediting the diagnosis and treatment of serious disease.
Statistical Data Analysis
Using the latest in data mining software, we focus on gathering information and knowledge from biopsy samples for the purpose of increasing predictive capabilities for disease prevention and treatment.
Systems Biology and Pathway Analysis
To ensure accurate data, we use multiple statistical models in our analysis of biopsy samples. This not only produces a deeper level of understanding of molecular information, but also drastically decreases the likelihood of producing false positive and false negative results.
Microarray and Proteomics Data Analysis
Recent advances in the field of microarray analysis have provided us with a powerful method for analyzing biopsy samples for protein expression. This method provides much richer information about the protein differential expression profiles, and is particularly useful in the estimation of false discovery rates and miss rates, further increasing the accuracy of our diagnostic data.
For more information about VBS molecular diagnostic technology, contact us at email@example.com
DISCLAIMER: The material provided on this site is strictly for informational purposes. Do not use this site as a substitute for medical care or medical advice. Please consult with your physician or other medical care provider regarding any medical questions you may have.